Combination chemotherapy and immunotherapy effective in Phase II leukemia study

Amadeo09 Nov, 2018Health

Results from a trial, led by Naval Daver, M.D., associate highbrow of Leukemia, were published in a Nov. 8 online emanate of Cancer Discovery. The investigate followed 70 patients with an normal of dual before treatments for relapsed AML, and reported a 33 percent altogether response with 22 percent of patients in finish remission.